Arcturus Therapeutics Holdings Inc.
ARCT · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Mar 2026
Open the dashboardInfographicSummary
FY2025 key figures
| $ | FY2025 | FY2024 | Change |
|---|---|---|---|
| Revenue | $82.0M | $152M | −46.1% |
| Operating income | −$76.3M | −$95.7M | +20.3% |
| Net income | −$65.8M | −$80.9M | +18.7% |
Latest quarter: Q3 2026
Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 5, 2026
| $ | Q3 2026 | Year earlier | Change |
|---|---|---|---|
| Revenue | $18.3M | $17.2M | +6.4% |
| Operating income | −$9.20M | −$16.5M | +44.2% |
| Net income | −$7.40M | −$13.4M | +44.8% |
Q3 2026 dashboardQ3 2026 infographic
Questions
- What was Arcturus's revenue in FY2025?
- $82.0M in FY2025 (Fiscal year ended Dec 31, 2025), −46.1% vs $152M a year earlier, per its 10-K filed Mar 2026.
- Was Arcturus profitable in FY2025?
- No: net income was −$65.8M and operating income −$76.3M in FY2025.
- What was Arcturus's revenue in Q3 2026?
- $18.3M (+6.4% vs a year earlier), per its Form 10-Q filed Nov 5, 2026.